Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue
+10.5%
EPS
+6.00%
Free cash flow
−1.84%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

101.43 0.61 +0.61%
Market cap
$58.1B
P/E
56.7×
Fwd P/E
36.5×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a

Edwards Lifesciences Corporation (EW) Total debt

Alert me on Total debt

Edwards Lifesciences Corporation's total debt at the end of fiscal 2025 was $598.3M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $598.8M. Over the past ten years it has ranged from $593.8M (fiscal 2018) to $1.0B (fiscal 2017); the current reading is higher than 82% of that period. Edwards Lifesciences Corporation ranks 27th of 147 Medical Devices companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $598.3M 0.10%
FY2024 $597.7M 0.12%
FY2023 $597.0M 0.12%
FY2022 $596.3M 0.10%
FY2021 $595.7M 0.12%
FY2020 $595.0M 0.10%
FY2019 $594.4M 0.10%
FY2018 $593.8M (42.71%)
FY2017 $1.0B 26.04%
FY2016 $822.3M 37.76%

Quarterly newest first

Period Total debt Change
Sep 2026 $598.8M 0.02%
Jun 2026 $598.7M 0.03%
Mar 2026 $598.5M 0.03%
Dec 2025 $598.3M 0.02%
43 more quarters

Against its own ten years

Low $593.8M High $1.0B
Ten-year median $596.9M
Current reading's percentile 82

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on EW